Humana Future Growth
Future criteria checks 1/6
Humana is forecast to grow earnings and revenue by 11.6% and 2% per annum respectively. EPS is expected to grow by 14.8% per annum. Return on equity is forecast to be 10.2% in 3 years.
Key information
11.6%
Earnings growth rate
14.8%
EPS growth rate
Healthcare earnings growth | 21.1% |
Revenue growth rate | 2.0% |
Future return on equity | 10.2% |
Analyst coverage | Good |
Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Nov 11Humana - Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over
Nov 05Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
Oct 28Positive Sentiment Still Eludes Humana Inc. (NYSE:HUM) Following 30% Share Price Slump
Oct 03Wall Street Lunch: Humana Shares Hit Hard
Oct 02Humana's Falling Share Price Gives Investors An Opportunity
Sep 18Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly
Sep 15Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Aug 19Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact
Jul 24Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings
Jul 16Humana: Medicare Advantage Will Never Be As Profitable As It Was
Jun 23Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885
Jun 20Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
Jun 06Humana Is Set Up For Long-Term Success
Jun 05Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885
May 21Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Apr 22Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly
Apr 20Humana: Where To Buy This
Apr 02Humana: This Year's Drop Might Have Created A Buying Opportunity
Mar 19Humana: A Golden Buying Opportunity As Fears Potentially Peaked
Feb 03Humana: The $300 Level Could Get Taken Out In The Near Future
Jan 25Humana: My Oh My, Another Strong Buy
Jan 14Humana: Buy This Powerful Dividend Growth Stock In The New Year
Jan 02Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?
Dec 14Humana: Failed Merger And Other Reasons To Buy
Dec 11Humana: Upgrade To Buy
Oct 06Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did
Sep 27We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease
Aug 25Humana: Mr. Market Got This One Right
Aug 03Humana: Recent Selloff Might Present A Buying Opportunity
Jul 13Humana: Rising Medical Costs Should Be Temporary
Jun 28Humana: Margin Expansion Supported By Growing Memberships
Jun 12Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly
May 26Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 13Humana Q4 2022 Earnings Preview
Jan 31Humana: Destined For A Long-Term Success
Jan 23Humana (NYSE:HUM) Could Easily Take On More Debt
Jan 13Humana receives $70.85B contract from Defense Health Agency
Dec 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 119,315 | 1,633 | 2,634 | 3,032 | 18 |
12/31/2025 | 118,760 | 1,909 | 2,532 | 3,103 | 19 |
12/31/2024 | 116,867 | 1,678 | 2,209 | 2,581 | 20 |
9/30/2024 | 115,010 | 1,359 | -4,344 | -3,640 | N/A |
6/30/2024 | 112,036 | 1,711 | -5,054 | -4,246 | N/A |
3/31/2024 | 109,243 | 1,991 | -3,241 | -2,283 | N/A |
12/31/2023 | 106,374 | 2,489 | 2,977 | 3,981 | N/A |
9/30/2023 | 102,351 | 3,015 | 4,992 | 5,988 | N/A |
6/30/2023 | 98,727 | 3,378 | 12,139 | 13,189 | N/A |
3/31/2023 | 95,642 | 3,115 | 9,907 | 10,972 | N/A |
12/31/2022 | 92,870 | 2,806 | 3,450 | 4,587 | N/A |
9/30/2022 | 91,485 | 2,807 | 8,385 | 9,618 | N/A |
6/30/2022 | 90,512 | 3,143 | 2,729 | 4,000 | N/A |
3/31/2022 | 87,495 | 3,035 | 2,080 | 3,401 | N/A |
12/31/2021 | 83,064 | 2,933 | 920 | 2,262 | N/A |
9/30/2021 | 82,201 | 2,673 | 1,400 | 2,641 | N/A |
6/30/2021 | 80,450 | 2,482 | 456 | 1,621 | N/A |
3/31/2021 | 78,888 | 3,722 | 3,266 | 4,328 | N/A |
12/31/2020 | 77,155 | 3,367 | 4,675 | 5,639 | N/A |
9/30/2020 | 74,388 | 4,153 | 4,970 | 5,868 | N/A |
6/30/2020 | 70,554 | 3,502 | 5,637 | 6,495 | N/A |
3/31/2020 | 67,716 | 2,614 | 4,073 | 4,862 | N/A |
12/31/2019 | 64,888 | 2,707 | 4,548 | 5,284 | N/A |
9/30/2019 | 62,761 | 2,550 | 3,757 | 4,439 | N/A |
6/30/2019 | 60,726 | 2,505 | 306 | 942 | N/A |
3/31/2019 | 58,740 | 1,758 | -1,234 | -617 | N/A |
12/31/2018 | 56,912 | 1,683 | 1,561 | 2,173 | N/A |
9/30/2018 | 55,933 | 1,512 | -989 | -405 | N/A |
6/30/2018 | 55,009 | 1,367 | N/A | 3,513 | N/A |
3/31/2018 | 54,284 | 1,824 | N/A | 3,532 | N/A |
12/31/2017 | 53,767 | 2,448 | N/A | 4,051 | N/A |
9/30/2017 | 53,456 | 1,863 | N/A | 4,189 | N/A |
6/30/2017 | 53,868 | 1,814 | N/A | 5,829 | N/A |
3/31/2017 | 54,341 | 1,475 | N/A | 5,639 | N/A |
12/31/2016 | 54,379 | 614 | N/A | 1,936 | N/A |
9/30/2016 | 54,862 | 1,116 | N/A | 5,046 | N/A |
6/30/2016 | 54,531 | 980 | N/A | 1,575 | N/A |
3/31/2016 | 54,256 | 1,100 | N/A | 1,263 | N/A |
12/31/2015 | 54,289 | 1,276 | N/A | 868 | N/A |
9/30/2015 | 53,256 | 1,320 | N/A | 724 | N/A |
6/30/2015 | 52,131 | 1,296 | N/A | 646 | N/A |
3/31/2015 | 50,621 | 1,209 | N/A | 1,054 | N/A |
12/31/2014 | 48,500 | 1,147 | N/A | 1,618 | N/A |
9/30/2014 | 46,359 | 972 | N/A | 1,409 | N/A |
6/30/2014 | 44,440 | 1,050 | N/A | 1,602 | N/A |
3/31/2014 | 42,539 | 1,126 | N/A | 1,975 | N/A |
12/31/2013 | 41,313 | 1,231 | N/A | 1,716 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HUM's forecast earnings growth (11.6% per year) is above the savings rate (2.6%).
Earnings vs Market: HUM's earnings (11.6% per year) are forecast to grow slower than the US market (15.3% per year).
High Growth Earnings: HUM's earnings are forecast to grow, but not significantly.
Revenue vs Market: HUM's revenue (2% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: HUM's revenue (2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HUM's Return on Equity is forecast to be low in 3 years time (10.2%).